News & Events

Impel NeuroPharma Announces Pricing of $45.0 Million Public Offering

SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced…


Impel DOC 2018 Team
Day of Caring in King County

September 24, 2018 — Thank you to everyone at Impel who gave their time to United Way of King County’s Day of Caring last Friday. The team volunteered to help spruce up B.F. Day Elementary in Fremont for a new school year.…


Impel 10 Years
Impel Celebrates 10 Years

August 24, 2008 — In 2008, Dr. John Hoekman was a Ph.D. student in pharmaceutics who had just won a UW business plan competition and was granted $25,000 to start his company. It’s been ten years since the incorporation of Impel…